Relay Therapeutics, Inc. — Director's Dealing 2021

May 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Relay Therapeutics, Inc. (RLAY)
CIK: 0001812364
Period of Report: 2021-05-19

Reporting Person: Shawver Laura (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-19	Stock Option (Right to Buy)	$30.09	A	16000	Acquired	2031-05-18	Common Stock (16000)	Direct

Footnotes

F1: This option was granted on May 19, 2021 with respect to 16,000 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.